Clinical Trial Update: IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial compares ingenol mebutate, 5-fluorouracil, imiquimod, and MAL-PDT for actinic keratosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Imiquimod (imiquimod)
• Ingenol Mebutate (ingenol mebutate)
• Methyl aminolevulinate (methyl aminolevulinate)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Keratosis, Actinic | Phase 4 | Status: UNKNOWN